Ayer Capital Management as of Sept. 30, 2012
Portfolio Holdings for Ayer Capital Management
Ayer Capital Management holds 31 positions in its portfolio as reported in the September 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Teva Pharmaceutical Industries (TEVA) | 10.2 | $24M | 581k | 41.41 | |
Grifols S A | 7.7 | $18M | 794k | 22.83 | |
ArthroCare Corporation | 7.5 | $18M | 548k | 32.40 | |
Celgene Corporation | 6.6 | $16M | 204k | 76.40 | |
Ariad Pharmaceuticals | 6.4 | $15M | 623k | 24.23 | |
Insmed (INSM) | 6.0 | $14M | 3.1M | 4.55 | |
Endologix | 5.8 | $14M | 1.0M | 13.82 | |
NPS Pharmaceuticals | 5.7 | $13M | 1.5M | 9.25 | |
Oncothyreon | 4.8 | $11M | 2.2M | 5.14 | |
Dynavax Technologies Corporation | 4.5 | $11M | 2.2M | 4.76 | |
McKesson Corporation (MCK) | 3.6 | $8.4M | 98k | 86.03 | |
CIGNA Corporation | 3.5 | $8.4M | 177k | 47.17 | |
Cardinal Health (CAH) | 2.9 | $6.8M | 174k | 38.97 | |
Threshold Pharmaceuticals | 2.6 | $6.2M | 855k | 7.24 | |
Sunesis Pharmaceuticals | 2.6 | $6.1M | 1.1M | 5.65 | |
Dendreon Corp cnv | 2.5 | $5.9M | 6.2M | 0.96 | |
Hologic (HOLX) | 2.2 | $5.1M | 253k | 20.24 | |
Chemocentryx | 2.1 | $5.1M | 435k | 11.63 | |
ZIOPHARM Oncology | 1.9 | $4.4M | 809k | 5.45 | |
Ym Biosciences | 1.6 | $3.7M | 2.0M | 1.84 | |
ShangPharma | 1.4 | $3.2M | 426k | 7.62 | |
Universal Health Services (UHS) | 1.3 | $3.1M | 68k | 45.74 | |
BioSpecifics Technologies | 1.2 | $2.8M | 142k | 19.42 | |
Neptune Technologies Bioreso | 1.1 | $2.6M | 650k | 3.95 | |
Biolinerx Ltd-spons | 1.1 | $2.5M | 957k | 2.63 | |
Celgene Corp right 12/31/2011 | 1.0 | $2.5M | 871k | 2.83 | |
Omeros Corporation (OMER) | 0.9 | $2.1M | 225k | 9.40 | |
Peregrine Pharmaceuticals Inc. cmn | 0.9 | $2.1M | 2.0M | 1.03 | |
Cyclacel Pharmaceuticals | 0.3 | $823k | 221k | 3.73 | |
Palatin Technologies | 0.3 | $763k | 1.1M | 0.67 | |
Cytokinetics | 0.2 | $415k | 500k | 0.83 |